|
Indian Pediatr 2019;56: 363-364 |
|
Healthy Growth is More Than Zinc
|
Tor A Strand
Professor, Department of Research, Innlandet Hospital
Trust, Lillehammer; and Centre for Intervention Science in Maternal and
Child Health, Centre for International Health, University of Bergen,
Bergen; Norway.
Email: [email protected]
|
Z inc is an essential micronutrient required for
proper immune function and growth [1]. Almost 50 years ago, it was
discovered that the rare inherited disorder Acrodermatitis enterophatica
was caused by impaired zinc absorption and that it could be effectively
treated with large doses of oral zinc [2]. Key features of this illness
are increased risk of infections and stunted growth. Stunting and a high
burden of infectious diseases seen in many marginalized populations were
then linked to poor zinc nutriture, recognizing possible public health
importance of zinc deficiency [3]. Several randomized controlled trials
(RCTs) on the effect of zinc in preventing infections and improving
growth was subsequently undertaken [4]. Two decades ago, the initial
efforts to summarize the effect of these trials confirmed a public
health relevance of zinc deficiency [5]. The initial evidence linking
stunting and zinc deficiency was so convincing that the prevalence of
stunting in a population was suggested as a proxy for zinc deficiency
[6].
In this issue, Gera and colleagues present the most
comprehensive meta-analysis on the effect of routine zinc
supplementation on growth [7]. Their analyses include data from almost
30,000 children under five years of age that participated in 63
different RCTs. The results are in line with most other meta-analyses
that demonstrate no, or a negligible effect of zinc on linear growth.
One of the outcomes they summarized were attained linear growth at the
end of the study periods. For this important outcome, the authors found
no effect of zinc whatsoever (Standardized effect size of 0.00; 95% CI
-0.07, 0.07). They also demonstrated no or minimal effects on other
anthropometric indices such as head circumference, weight, and mid-upper
arm circumference. Similar to the previous systematic reviews, this
review also demonstrated substantial heterogeneity between the studies.
In other words, the effect of zinc on growth varies significantly
between the RCTs. This variability is expected, as the impact of
nutrient interventions likely vary according to the preexisting nutrient
status of the populations or the degree to which the community is
affected by the outcome of interest. It is therefore noteworthy that the
observed heterogeneity of zinc cannot be explained by preexisting zinc
status or the prevalence of stunted growth. Furthermore, micronutrient
deficiencies often coexist and supplementing with one growth-limiting
nutrient is unlikely to work if other nutrients necessary for growth is
lacking.
Zinc supplementation reduces the risk and duration of
infections [4], and frequent and persistent infections may hamper
growth. The effect of zinc seen in some studies may accordingly be
mediated through its impact on preventing or curbing infections. This
potential indirect effect of zinc on growth depends on the nature and
burden of infections and availability of the health services for the
study population. These background variables could partly explain the
heterogeneity between the different RCTs but such effect is not easy to
measure.
It should be noted that a lack of a consistent
beneficial effect of zinc supplementation on growth does not undermine
the importance of this nutrient on human health. Nor does the results of
this meta-analysis rule out zinc deficiency as one of many causes of
stunted growth. However, the conclusion to not advocate zinc
supplementation "as a public health measure to improve growth" is well
justified in light of their findings and the expected costs of zinc
supplementation programs. Another important point made by the authors is
that the multifaceted origin of stunting and the limited effect of zinc
question the use of stunting as a proxy for zinc deficiency.
We should continue our efforts to identify modifiable
risk factors for stunted growth in marginalized populations. Zinc is one
of these factors but seemingly not as important as previously assumed.
However, despite the limited effect on growth, adequate intake of this
essential micronutrient should be encouraged.
References
1. Walsh CT, Sandstead HH, Prasad AS, Newberne PM,
Fraker PJ. Zinc: health effects and research priorities for the 1990s.
Environ Health Perspect. 1994;2:5-46.
2. Neldner KH, Hambidge KM. Zinc therapy of
acrodermatitis enteropathica. N Engl J Med. 1975;292: 879-82.
3. Sandstead HH. Zinc deficiency. A public health
problem? Am J Dis Child. 1991;145:853-9.
4. Mayo-Wilson E, Junior JA, Imdad A, Dean S, Chan
XHS, Chan ES, et al. Zinc supplementation for preventing
mortality, morbidity, and growth failure in children aged 6 months to 12
years of age. Cochrane Database Syst Rev. 2014;15:CD009384.
5. Brown KH, Wuheler SE. Zinc and Human Health:
Results of Recent Trials and Implications for Program Interventions and
Research. Ottawa: The Micronutrient Initiative, 2000.
6. International Zinc Nutrition Consultative Group (IZiNCG),
Brown KH, Rivera JA, Bhutta Z, Gibson RS, King JC, et al.
International Zinc Nutrition Consultative Group (IZiNCG) technical
document #1. Assessment of the risk of zinc deficiency in populations
and options for its control. Food Nutr Bull. 2004;25: S99-203.
7. Gera T, Shah D, Sachdev HPS. Zinc supplementation
for promoting growth in children under 5 years of age in low- and
middle-income countries: A systematic review. Indian Pediatr.
2019;56:391-406.
|
|
|
|